Gene · 1213
NIH grants2,119
NIH grants whose papers are about the gene, through NIH's grant-paper links.
701 to 720 of 2,119
Download this page as JSON| Grant | Title | CLTC papers | Newest fiscal year |
|---|---|---|---|
| R01CA207504 | The role of TAZ in breast cancer initiation and progression | 1 | 2021 |
| R01CA210192 | Targeted Nanotherapy for Pancreatic Cancer | 1 | 2021 |
| R01CA211912 | Regulation of non-proteolytic ubiquitination in cancer chemoresistance and progression | 1 | 2021 |
| R01DK078121 | Improving the Diagnosis of Congenital Genitourinary Birth Defects | 1 | 2021 |
| R01DK091392 | Klotho and Phosphate in Chronic Kidney Disease: Pathogenesis and Therapeutics | 1 | 2021 |
| R01DK091623 | Proximal Tubule Albumin Transport in Disease States. | 1 | 2021 |
| R01DK110186 | Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance | 1 | 2021 |
| R01DK112262 | The Role of Adipose-Resident T Cells in HIV-Associated Glucose Intolerance | 1 | 2021 |
| R01ES019672 | Manganese-related neurotoxicity in asymptomatic welders | 1 | 2021 |
| R01GM058038 | Tension-dependent regulation of alpha-catenin during morphogenesis in C. elegans | 1 | 2021 |
| R01GM067848 | Degradation of dying cells | 1 | 2021 |
| R01GM068803 | Structure and Function of the Exocyst Complex | 1 | 2021 |
| R01GM107214 | Regulation of Cytoplasmic Dynein | 1 | 2021 |
| R01GM114102 | Interaction of the TMEM127 tumor suppressor with the mTORC1 lysosomal activating complex | 1 | 2021 |
| R01GM121750 | The prevalence of genetic introgression in speciation | 1 | 2021 |
| R01GM121920 | Microfluidic Chip for the Analysis of Cell-Surface Proteins | 1 | 2021 |
| R01GM123018 | Mechanisms of heterochromatin replication | 1 | 2021 |
| R01GM123048 | Chromatin Expulsion by the DNA Replication Licensing Factor ORC4 during Asymmetric Cell Division in Meiosis and Differentiation | 1 | 2021 |
| R01GM124334 | Structure mapping of molecular complexes by super-resolution microscopy | 1 | 2021 |
| R01GM125639 | Quantifying molecular consequences of human missense variants with large-scale interactome perturbation studies | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1213/grants?page=36